Against the backdrop of high prices for the original ponatinib, the generic version produced by Lao Big Bear Pharmaceutical has entered the market at ···【Read More】
Update: 2026-06-18Source: Haiou HealthViews: 130
The generic version of ponatinib, PONADX, launched by BigbearPharma in Laos, is a third-generation tyrosine kinase inhibitor for Philadelphia chromoso···【Read More】
Update: 2026-06-18Source: Haiou HealthViews: 137
The alectinib generic version launched by Lao Big Bear Pharmaceutical has demonstrated significant efficacy and favorable long-term safety in multiple···【Read More】
Update: 2026-06-18Source: Haiou HealthViews: 129
As one of the national formal chemical pharmaceutical enterprises in Laos, Laos Big Bear Pharmaceutical Co., Ltd. produces alectinib generics based on···【Read More】
Update: 2026-06-18Source: Haiou HealthViews: 125
For many ALK-positive non-small cell lung cancer patients, the alectinib generic produced by BigbearPharma in Laos offers a more affordable path for l···【Read More】
Update: 2026-06-18Source: Haiou HealthViews: 124
Apalutamide, as a second-generation high-selectivity androgen receptor antagonist, has an affinity for the androgen receptor more than 5 times that of···【Read More】
Update: 2026-06-17Source: Haiou HealthViews: 134
BigBearPharma, headquartered in Vientiane, Laos, is a legitimate chemical pharmaceutical enterprise established in 2020 that has passed Laos's new···【Read More】
Update: 2026-06-17Source: Haiou HealthViews: 149
Facing the treatment cost of thousands of yuan per box for the original apalutamide in China, the apalutamide generic APADX launched by Laos Big Bear ···【Read More】
Update: 2026-06-17Source: Haiou HealthViews: 134
Leveraging Laos' increasingly mature generic pharmaceutical industrial system, the bedaquiline produced by DaXiong Pharmaceutical has established ···【Read More】
Update: 2026-06-17Source: Haiou HealthViews: 147
For countless families deeply trapped in the dilemma of drug-resistant tuberculosis, the Lao Daxiong version of Bedaquiline represents not only a ther···【Read More】
Update: 2026-06-17Source: Haiou HealthViews: 125
Amidst the dual challenges of drug accessibility and prohibitive costs confronting global multidrug-resistant tuberculosis (MDR-TB) treatment, the bed···【Read More】
Update: 2026-06-17Source: Haiou HealthViews: 126
As a second-generation ALK tyrosine kinase inhibitor, brigatinib manufactured by Lao Big Bear Pharmaceutical specifically inhibits the activity of ALK···【Read More】
Update: 2026-06-16Source: Haiou HealthViews: 126
As one of the national standard pharmaceutical enterprises in Laos, Big Bear Pharmaceutical has launched a generic version of Brigatinib, manufactured···【Read More】
Update: 2026-06-16Source: Haiou HealthViews: 128
The generic version of Brigatinib launched by BigbearPharma in Laos is an oral targeted therapy for the treatment of anaplastic lymphoma kinase (ALK)-···【Read More】
Update: 2026-06-16Source: Haiou HealthViews: 128
As a new generation highly selective JAK3/TEC dual inhibitor, Ritlecitinib launched by Lao Big Bear Pharmaceutical brings new hope for treatment to gl···【Read More】
Update: 2026-06-15Source: Haiou HealthViews: 139
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos